Myocardial Infarction Type 4b in Human Immunodeficiency Virus-Infected Patient

We report a case of a 52-year-old human immunodeficiency virus (HIV)-infected male patient receiving combined antiretroviral therapy (cART), who presented with acute ST-elevation myocardial infarction (STEMI). He was properly treated (e.g., prescribed anti-coagulation drugs: aspirin, clopidogrel, en...

Descripción completa

Detalles Bibliográficos
Autores principales: Cybula-Walczak, Aneta, Szymanski, Filip M., Platek, Anna E., Karpinski, Grzegorz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society of Cardiology 2014
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3905115/
https://www.ncbi.nlm.nih.gov/pubmed/24497889
http://dx.doi.org/10.4070/kcj.2014.44.1.42
Descripción
Sumario:We report a case of a 52-year-old human immunodeficiency virus (HIV)-infected male patient receiving combined antiretroviral therapy (cART), who presented with acute ST-elevation myocardial infarction (STEMI). He was properly treated (e.g., prescribed anti-coagulation drugs: aspirin, clopidogrel, enoxaparin) and discharged. After 1.5 months, another STEMI related with in-stent thrombosis took place. The cART scheme was altered, resulting in no further cardiac events in the follow-up period, with undetectable levels of HIV ribonucleic acid. This case highlights the association between HIV infection and the specific drugs of cART, and the risk of cardiovascular disease development.

Ejemplares similares